Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01522131 · ClinicalTrials.gov registry record · NA

Effect of Laser Use on Guided Tissue Regeneration in Treatment of Molar Teeth With Class 2 Furcation Affected by Periodontitis

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT01522131 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01522131, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

Purpose: The proposed study will evaluate and compare the clinical response of using bioresorbable collagen membrane alone or defect debridement with erbium Laser irradiation in conjunction with bioresorbable collagen membrane in the treatment of Class II furcation defects in maxillary and mandibular teeth. The study will examine whether there is a superior regeneration potential when the laser energy is combined with membrane defect isolation. Procedure: The study will use 2 groups, a control group and a test group with 16 patients in each group, with severe chronic periodontitis having clinical or radiographic evidence of Class II furcation defects in the buccal or lingual of the mandibular molars or Class II furcation defects on the buccal of maxillary molars. 16 patients will serve as the control group and open flap debridement with bioresorbable collagen membrane will be the mode of treatment. Group 2: 16 patients will serve as the test group and will undergo open flap debridement in conjunction with Er, Cr: YSGG laser irradiation and a bioresorbable collagen membrane will be used.

Interventions

  • PROCEDURE bioresorbable membrane alonewill be used for regeneration of the periodontium(control)

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2011-12
Est. Completion 2013-06
Phase NA

What the Registry Record Tells You About NCT01522131

The ClinicalTrials.gov registry entry for NCT01522131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which bioresorbable membrane alonewill be used for regeneration of the periodontium(control) is the first listed.

NCT01522131 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01522131 about?

NCT01522131 is a clinical study titled "Effect of Laser Use on Guided Tissue Regeneration in Treatment of Molar Teeth With Class 2 Furcation Affected by Periodontitis". Purpose: The proposed study will evaluate and compare the clinical response of using bioresorbable collagen membrane alone or defect debridement with erbium Laser irradiation in conjunction with bioresorbable collagen membrane in the treatment of Class II furcation defects in maxillary and mandibula...

What is the current status of trial NCT01522131?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2011-12. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01522131?

The interventions under investigation include: bioresorbable membrane alonewill be used for regeneration of the periodontium(control) (PROCEDURE).

Who is sponsoring clinical trial NCT01522131?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.